Personalised treatment in melanoma: matching optimal drug therapies for individual patients to improve survival.

黑色素瘤的个性化治疗：为个体患者匹配最佳药物治疗以提高生存率。

• 批准号: nhmrc : 2005253
• 金额: $ 13.27万
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2021
• 资助国家: 澳大利亚
• 起止时间: 2021-01-01 至 2027-12-31
• 项目状态: 未结题
• 来源: https://researchdata.edu.au/personalised-treatment-melanoma-improve-survival/1780524
• 关键词: Personalised; treatment; melanoma; matching; optimal

The best treatment for melanoma currently is immunotherapy. However, most patients become resistant to immunotherapy after an initial response. When this occurs, patients are treated with new medications, often in a clinical trial. Unfortunately, doctors cannot predict if a patient is going to respond to a particular new treatment. This project will study the makeup of individual melanomas and use this to recommend which new treatment is most likely to work for the patient.

目前治疗黑色素瘤的最佳方法是免疫疗法。然而，大多数患者在初始反应后对免疫治疗产生耐药性。当这种情况发生时，患者通常在临床试验中接受新药治疗。不幸的是，医生无法预测病人是否会对一种特定的新疗法产生反应。这个项目将研究单个黑色素瘤的构成，并以此来推荐哪种新的治疗方法最有可能对患者有效。